Valuation

Valuation of Complex Derivatives and Securities

Valuation of Complex Derivatives and Securities

Understanding the economics of valuation is essential in all but the simplest of settings. NERA provides valuation expertise in three general contexts: business valuation, tangible asset valuation, and financial asset valuation.

In the context of business and tangible asset valuation, NERA has utilized valuation methodologies which are based on company comparables and earnings multiples, the values of other assets from the same company or portfolio, financial modeling and estimation of the company's future cash flows, and comparisons to valuations of benchmark assets in the public domain.

For financial and quasi-financial assets and derivatives contracts, our valuations techniques leverage generally accepted discounted cash flows and mark-to-market methods, derivatives option models, real options techniques, probability-weighted and dynamic cash flow models, custom simulation models, reference/inference-based comparables approaches, and zero-arbitrage calculation techniques. Our experience in a variety of asset classes allows us to quickly assess market specifics, identify important and potentially unique valuation characteristics of the asset, assess the impact of market economics on market value, and use defendable, industry standard methods to derive a fair valuation. With the ability to combine economics, finance, statistics, and econometrics, NERA’s experts can execute valuation methods that go beyond traditional approaches to valuation, especially in cases where historical data and other valuation benchmarks are either unavailable or considered inadequate.

Name Title Location Phone Email
Lucy P. Allen Senior Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Dr. Vinita Juneja Senior Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice
New York City
London
Toronto
+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314
vinita.juneja@nera.com
Dr. Denise Neumann Martin Senior Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. Faten Sabry Senior Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Kurt G. Strunk Senior Managing Director New York City +1 212 345 5035 kurt.strunk@nera.com
Dr. Ling Ling Ang Managing Director Washington, DC
Chicago
+1 202 466 9259
+312 573 2827
lingling.ang@nera.com
Dr. Jordan Milev Managing Director New York City +1 212 345 5516 jordan.milev@nera.com
Dr. Airat Chanyshev Director New York City +1 212 345 7336 airat.chanyshev@nera.com
William P. Hrycay Director New York City +1 212 345 1518 william.hrycay@nera.com
Timothy McKenna Director Los Angeles
New York City
+1 213 346 3041
+1 212 345 3000
timothy.mckenna@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London
+1 212 345 5407
+44 20 7659 8500
andrew.carron.affiliate@nera.com
Title Type Author
Recent Trends in Securities Class Action Litigation: H1 2023 Update Report Edward Flores and Svetlana Starykh
Snapshot of Recent Trends in Asbestos Litigation: 2022 Update White Paper Mary Elizabeth Stern and Lucy Allen
How Will the LIBOR Transition Affect Mortgage Consumers? White Paper Dr. Faten Sabry and Ramisa Roya, et al.
Trends in Canadian Securities Class Actions: 2021 Update White Paper Bradley A. Heys, Robert Patton, Jielei Mao
‘Coca-Cola’ vs. Section 482: Is It Time to Refresh the Regulatory Guidance? Published Article Dr. Harlow Higinbotham and Dr. Niraja Srinivasan
Snapshot of Recent Trends in Asbestos Litigation 2021 Update Mary Elizabeth C. Stern and Lucy P. Allen
NERA Experts Contribute Chapter to "The Future of the Profit Split Method" Book Dr. Harlow Higginbotham and Dr. Vladimir Starkov
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Transfer Pricing Roundtable in Financier Worldwide. Expert QA Dr. Vladimir Starkov and Philip de Homont
Amount B: Facts and Circumstances Matter—Even for Routine Distributors Published Article Dr. Harlow Higinbotham and Dr. Vladimir Starkov